BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of nitric oxide
,
Doxorubicin
,
rs7903146
,
KLK3
,
Influenza
,
Liver
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
complement inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Protein therapeutics and their lessons: Expect the unexpected when inhibiting the multi-protein casc…
The effects of exercise on complement system proteins in humans: a systematic scoping review.
Molecular Basis for Bordetella pertussis Interference with Complement, Coagulation, Fibrinolytic, an…
Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma.
Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related ma…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
BCX9930 for the Treatment of PNH in Subjects Not Receiving Other Complement Inhibitor Therapy
Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome …
Study of Efficacy and Safety of Twice Daily Oral Iptacopan (LNP023) in Adult PNH Patients Who Are Na…
First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers
Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Aty…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ